Since announcing her multiple sclerosis diagnosis in 2018, Selma Blair has been an outspoken advocate for people with MS. The ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

We asked experts which symptoms are most likely to be misdiagnosed as anxiety.

Speaking about the incident, the mum said: “I was met with the most abusive woman who ridiculed me and my disability. “I ...

A woman who died of a heart attack in an emergency department was misdiagnosed as having an adverse reaction to codeine, a ...

A young bowel cancer patient has shared five symptoms of the life-threatening disease she ignored before being diagnosed.

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

Glaucoma, known as the 'silent thief of sight', often has no noticeable symptoms until significant damage occurs. Symptoms ...

The FDA reported that six patients died after being injected with Teva’s Copaxone or Sandoz’s Glatopa. The US Food and Drug ...

FDA issues new warnings about rare but severe allergic reactions, including anaphylaxis, linked to MS drug glatiramer acetate, urging immediate medical attention.

Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.